Patents by Inventor Clare Burn Aschner

Clare Burn Aschner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using HSV-2 single cycle virus delta-gD and HSV-2 recombinant glycoprotein D
    Patent number: 11684670
    Abstract: Methods of vaccinating, immunizing and/or treating a subject against a herpes simplex virus infection or a disease caused by a herpes simplex virus infection comprise administering to the subject an effective amount of a HSV-2 single-cycle virus and an effective amount of a recombinant HSV-2 glycoprotein D, wherein the HSV-2 single-cycle virus comprises HSV-2 having a deletion of glycoprotein D-encoding gene in the genome and the HSV-2 is phenotypically complemented with an HSV-1 glycoprotein D on a lipid bilayer of the HSV-2.
    Type: Grant
    Filed: June 1, 2021
    Date of Patent: June 27, 2023
    Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE
    Inventors: Betsy C. Herold, Clare Burn Aschner
  • METHODS OF USING HSV-2 SINGLE CYCLE VIRUS DELTA-GD AND HSV-2 RECOMBINANT GLYCOPROTEIN D
    Publication number: 20210369838
    Abstract: Methods of vaccinating, immunizing and/or treating a subject against a herpes simplex virus infection or a disease caused by a herpes simplex virus infection comprise administering to the subject an effective amount of a HSV-2 single-cycle virus and an effective amount of a recombinant HSV-2 glycoprotein D, wherein the HSV-2 single-cycle virus comprises HSV-2 having a deletion of glycoprotein D-encoding gene in the genome and the HSV-2 is phenotypically complemented with an HSV-1 glycoprotein D on a lipid bilayer of the HSV-2.
    Type: Application
    Filed: June 1, 2021
    Publication date: December 2, 2021
    Inventors: Betsy C. HEROLD, Clare Burn Aschner